Specialized Programs of Research Excellence (SPOREs)

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

In 1992, the NCI established the Specialized Programs of Research Excellence (SPORE). The NCI Translational Research Program (TRP) is the home of the SPOREs, and a cornerstone of NCI’s efforts to promote collaborative, interdisciplinary translational cancer research. SPORE grants involve both basic and clinical/applied science, and support projects that will result in new and diverse approaches to the prevention, early detection, diagnosis and treatment of human cancers.

Each SPORE focuses on a specific organ site, such as breast or lung cancer, or on a group of highly related cancers, such as gastrointestinal cancers. SPOREs are designed to enable the rapid and efficient movement of basic scientific findings into clinical settings, as well as to determine the biological basis for observations made in individuals with cancer or in populations at risk for cancer.

Download Table Data

FY 2015 Funding for SPORE Grants
(Whole Dollars)
Mechanism Site Number Amount
P50 SPOREs Brain 5 $10,785,138
Breast 5 10,613,001
Cervical 1 2,174,869
Genitourinary 2 4,115,400
Gastrointestinal 4 8,605,199
Head and Neck 3 6,049,831
Leukemia 2 4,423,421
Lung 3 6,411,142
Lymphoma 3 6,503,359
Melanoma 1 2,185,000
Ovarian 4 6,183,068
Pancreatic 3 6,555,002
Prostate 6 12,434,808
Skin 4 8,254,611
Uterine 3 6,555,000
P50 Subtotal   49 101,848,849
Co-funded Head & Neck with NIDCR 0 831,000
Total Co-funded     831,000
Total SPOREs   49 $102,679,849
  • Posted: December 16, 2016